NCT04052373 Peri-implantitis Implantoplasty Treatment
| NCT ID | NCT04052373 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oslo |
| Condition | Peri-Implantitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 35 participants |
| Start Date | 2019-10-15 |
| Primary Completion | 2027-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 35 participants in total. It began in 2019-10-15 with a primary completion date of 2027-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This double arm, split-mouth, single centre, controlled, randomised clinical study is designed to examine the effect of implantoplasty in treatment of peri-implantitis. Peri-implantitis will be treated with open flap debridement, with or without implantoplasty.
Eligibility Criteria
Inclusion Criteria: * Peri-implantitis (according to 2018 criteria) on minimum 2 implants of similar surface and defect type * Competent to give consent * Exposed, modified implant surface with loss \>2mm Exclusion Criteria: * Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term corticosteroid treatment * Present or past use of bisphosphonate treatment • Pregnant or nursing subjects * Patients classified as \> class II according to ASA classification * Implant unavailable for implantoplasty treatment * Inhability to comprehend and respond to the quality of life questionnaire * Examiners/operators deem original placement of implant (angle, position) suboptimal and considered to play a major role in development of peri-implantitis * History of peri-implantitis surgery prior to 6 months of screening
Frequently Asked Questions
Who can join the NCT04052373 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Peri-Implantitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04052373 currently recruiting?
Yes, NCT04052373 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Oslo to inquire about joining.
Where is the NCT04052373 trial being conducted?
This trial is being conducted at Oslo, Norway, Oslo, Norway.
Who is sponsoring the NCT04052373 clinical trial?
NCT04052373 is sponsored by University of Oslo. The trial plans to enroll 35 participants.